Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Diana N. Amaya"'
Autor:
Sivareddy Kotla, Aijun Zhang, Masaki Imanishi, Kyung Ae Ko, Steven H. Lin, Young Jin Gi, Margie Moczygemba, Sevinj Isgandarova, Keri L. Schadler, Caroline Chung, Sarah A. Milgrom, Jose Banchs, Syed Wamique Yusuf, Diana N. Amaya, Huifang Guo, Tamlyn N. Thomas, Ying H. Shen, Anita Deswal, Joerg Herrmann, Eugenie S. Kleinerman, Mark L. Entman, John P. Cooke, Giovanni Schifitto, Sanjay B. Maggirwar, Elena McBeath, Anisha A. Gupte, Sunil Krishnan, Zarana S. Patel, Yisang Yoon, Jared K. Burks, Keigi Fujiwara, Paul S. Brookes, Nhat-Tu Le, Dale J. Hamilton, Jun-ichi Abe
Publikováno v:
Redox Biology, Vol 47, Iss , Pp 102132- (2021)
The incidence of cardiovascular disease (CVD) is higher in cancer survivors than in the general population. Several cancer treatments are recognized as risk factors for CVD, but specific therapies are unavailable. Many cancer treatments activate shar
Externí odkaz:
https://doaj.org/article/e0a94c31b512406eaddff3363f57a4c3
Autor:
Valerie Klairisa Reed, Daniel Buchholz, Elizabeth S. Bloom, Benjamin Smith, Kelly K. Hunt, Isidora Arzu, Simona F. Shaitelman, Karen E. Hoffman, Eric A. Strom, Tomas Dvorak, Welela Tereffe, George H. Perkins, Wendy A. Woodward, Gabriel N. Hortobagyi, Diana N Amaya, Emily Grade, Michael C. Stauder, Thomas A. Buchholz, Alastair M. Thompson, Gregory M. Chronowski, Yu Shen, Xiudong Lei, Shalin J. Shah, Pamela J. Schlembach
Publikováno v:
Journal of Clinical Oncology. 36:3495-3503
Purpose The adoption of hypofractionated whole-breast irradiation (HF-WBI) remains low, in part because of concerns regarding its safety when used with a tumor bed boost or in patients who have received chemotherapy or have large breast size. To addr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b25cacdafcebdcc8eb0239dc6ce69301
https://doi.org/10.1200/jco.18.00317
https://doi.org/10.1200/jco.18.00317
Autor:
Chao Gao, Ran An, Yan Wang, Akshara Singareeka Raghavendra, Jing Li, Yon Son Betty Kim, Fuchenchu Wang, Diana N Amaya, Tina Marie Briere
Publikováno v:
Neuro-Oncology Advances. 3:iii21-iii22
Background As systemic therapy for metastatic breast cancer (BC) improves, the survival benefit from hormonal and targeted therapy urges treatment of brain metastases (BMs) with minimal toxicity and less systemic therapy interruption. Here we assesse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ead90527bfb35c8fd60615820db23e9
https://doi.org/10.1093/noajnl/vdab071.088
https://doi.org/10.1093/noajnl/vdab071.088
Autor:
Elizabeth S. Bloom, Isidora Arzu, Gabriel N. Hortobagyi, Eric A. Strom, Patrick J. Kelly, Michael C. Stauder, Alastair M. Thompson, Diana N Amaya, V. Reed, Gregory M. Chronowski, Xiudong Lei, Sanjiv J. Shah, George H. Perkins, Thomas A. Buchholz, Tomas Dvorak, W.A. Woodward, D Baumann, PJ Schlembach, M Morrison, B.D. Smith, K. K. Hunt, Emily Grade, Welela Tereffe, D.J. Buchholz, Simona F. Shaitelman, Karen E. Hoffman, William Guerra
Publikováno v:
Cancer Research. 78:P2-11
Background: Adoption of HF-WBI remains low due in part to concerns regarding its safety when used with a tumor bed boost or in patients who have received chemotherapy or have large breast size. To address this, we conducted a randomized, multicenter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1783db57e89233da779ce38c5dd8b047
https://doi.org/10.1158/1538-7445.sabcs17-p2-11-02
https://doi.org/10.1158/1538-7445.sabcs17-p2-11-02
Autor:
Masaki Imanishi, Ying H. Shen, Eugenie S. Kleinerman, Yisang Yoon, Sevinj Isgandarova, Tamlyn N. Thomas, Elena McBeath, Sunil Krishnan, Anisha A. Gupte, Sarah A. Milgrom, Zarana S. Patel, Sanjay B. Maggirwar, Jared K. Burks, Nhat-Tu Le, Diana N Amaya, Mark L. Entman, Jose Banchs, Kyung Ae Ko, John P. Cooke, Sivareddy Kotla, Jun Ichi Abe, Margie Moczygemba, Aijun Zhang, Keri Schadler, Giovanni Schifitto, Dale J. Hamilton, Steven H. Lin, Joerg Herrmann, Keigi Fujiwara, Young Jin Gi, Paul S. Brookes, Anita Deswal, Syed Wamique Yusuf, Caroline Chung, Huifang Guo
Publikováno v:
Redox Biology, Vol 47, Iss, Pp 102132-(2021)
Redox Biology
Redox Biology
The incidence of cardiovascular disease (CVD) is higher in cancer survivors than in the general population. Several cancer treatments are recognized as risk factors for CVD, but specific therapies are unavailable. Many cancer treatments activate shar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0115992686e60d94e365e4aaf687d45
https://doi.org/10.1016/j.redox.2021.102132
https://doi.org/10.1016/j.redox.2021.102132
Autor:
Fuchenchu Wang, Nuhad K. Ibrahim, Jing Li, Akshara Singareeka Raghavendra, Ran An, Yan Wang, Diana N Amaya, Chao Gao
Publikováno v:
Neuro-Oncology Advances. 3:iii21-iii21
Background Triple-negative breast cancer (TNBC) is an aggressive subtype with high propensity of developing brain metastases (BM). Clinical outcomes and prognostic factors after stereotactic radiosurgery (SRS) for BM were not well defined. Methods We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7110715f377a7c97ba0d510d727d77b7
https://doi.org/10.1093/noajnl/vdab071.087
https://doi.org/10.1093/noajnl/vdab071.087
Autor:
Jonathan Nguyen, Lili Lin, Chidinma P. Anakwenze Akinfenwa, Albert C. Koong, Matthew S. Ning, Debra Nana Yeboa, Zhongxing Liao, Victoria Cox, Diana N Amaya, Benjamin Smith, Beth De Gracia, Brian De, Hanh Hoang, Sam Beddar
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100676-(2021)
Advances in Radiation Oncology
Advances in Radiation Oncology
Introduction Clinical trial enrollment has declined globally due to the COVID-19 pandemic. This underscores the importance of structured methods to continue critical medical research safely and efficiently. Methods We report the impact of a phased tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb8379681bf914feeca5c13ae6f6679
https://doi.org/10.1016/j.adro.2021.100676
https://doi.org/10.1016/j.adro.2021.100676
Autor:
Fuchenchu Wang, Diana N Amaya, Nuhad K. Ibrahim, Jing Li, Yan Wang, Akshara Singareeka Raghavendra, Ran An, Chao Gao
Publikováno v:
Cancer Research. 81:PS15-10
Background: Triple-negative breast cancer (TNBC) has a high propensity for brain metastasis (BM) with poor prognosis. Stereotactic radiosurgery (SRS) has emerged as an effective treatment option for BM. However, clinical outcomes after SRS for BM fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6e38eb88b9086cd1933783691ee602a
https://doi.org/10.1158/1538-7445.sabcs20-ps15-10
https://doi.org/10.1158/1538-7445.sabcs20-ps15-10
Autor:
Diana N Amaya, Sangeetha M. Reddy, Jay Reddy, Welela Tereffe, Michael C. Stauder, Wendy A. Woodward, Simona F. Shaitelman, Pamela K. Allen, Susan G. Lakoski, Abigail S. Caudle, Naoto T. Ueno, William Guerra, Bradley J. Atkinson
Publikováno v:
Journal of Cancer
Purpose: We sought to investigate if the use of HMG Co-A reductase inhibitors (statins) has an impact on outcomes among patients with triple negative breast cancer (TNBC). Methods: We reviewed the cases of women with invasive, non-metastatic TNBC, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf6ceeeafce185f0ae580890e7dabc99
https://pubmed.ncbi.nlm.nih.gov/28819403
https://pubmed.ncbi.nlm.nih.gov/28819403
Autor:
Welela Tereffe, Diana N Amaya, Bradley J. Atkinson, Sangeetha M. Reddy, W.A. Woodward, Abigail S. Caudle, Stacy L. Moulder, William Guerra, Michael C. Stauder, NT Ueno, Susan G. Lakoski, Simona F. Shaitelman, Pamela K. Allen, Jay Reddy
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:E48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a47b757eb354d793c34b254f66f12df
https://doi.org/10.1016/j.ijrobp.2016.06.714
https://doi.org/10.1016/j.ijrobp.2016.06.714